Portage Biotech (PRTG) News Today $5.96 +0.11 (+1.88%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Portage Biotech Shares Double on Letter of Intent to Sell SubsidiaryDecember 17, 2024 | marketwatch.comPortage Biotech Stock More Than Doubles On Immunova Deal Potential: Retail Sees Big OpportunityDecember 17, 2024 | msn.comPortage Biotech Inc.: Portage Biotech Announces Receipt of Nasdaq Noncompliance LetterDecember 14, 2024 | finanznachrichten.dePortage Biotech receives noncompliance notification from NasdaqDecember 14, 2024 | markets.businessinsider.comPortage Biotech Inc. Appoints New CEO Amid Leadership ChangeDecember 13, 2024 | tipranks.comPortage Biotech (NASDAQ:PRTG) Trading Up 0.3% - What's Next?December 13, 2024 | americanbankingnews.comPortage Biotech Announces Receipt of Nasdaq Noncompliance LetterDecember 12, 2024 | globenewswire.comPortage Biotech Announces Key Leadership ChangesDecember 7, 2024 | markets.businessinsider.comPortage Biotech Reports Reduced Losses and Strategic PlansNovember 26, 2024 | tipranks.comPortage Biotech Inc. Reports Asset and Liability ChangesNovember 26, 2024 | tipranks.comPortage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024November 26, 2024 | globenewswire.comPortage Biotech's Market Cap Drops To US$4.3m Leaving Insiders With LossesNovember 17, 2024 | finance.yahoo.comUnited States shares lower at close of trade; Dow Jones Industrial Average down 0.25%September 19, 2024 | msn.comU.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.59%August 30, 2024 | msn.comShort Interest in Portage Biotech Inc. (NASDAQ:PRTG) Decreases By 88.1%Portage Biotech Inc. (NASDAQ:PRTG - Get Free Report) saw a significant drop in short interest in the month of August. As of August 15th, there was short interest totalling 7,200 shares, a drop of 88.1% from the July 31st total of 60,600 shares. Currently, 0.1% of the company's shares are short sold. Based on an average daily trading volume, of 881,800 shares, the days-to-cover ratio is currently 0.0 days.August 27, 2024 | marketbeat.comPortage Biotech (NASDAQ:PRTG) Stock, Short Interest ReportAugust 25, 2024 | benzinga.comPortage Biotech Inc.August 25, 2024 | wsj.comPortage Biotech (NASDAQ:PRTG) Stock Quotes, Forecast and News SummaryAugust 24, 2024 | benzinga.comPRTG Stock Earnings: Portage Biotech Reported Results for Q4 2024August 15, 2024 | investorplace.comPortage Biotech Inc.: Portage Biotech Announces 1-for-20 Reverse Stock SplitAugust 14, 2024 | finanznachrichten.dePortage Biotech Announces 1-for-20 Reverse Stock SplitAugust 13, 2024 | finance.yahoo.comPortage Biotech Inc. (PRTG)July 27, 2024 | finance.yahoo.comPortage Biotech Inc (PRTG)May 16, 2024 | uk.investing.comPortage Biotech halts trial enrollment, seeks strategic optionsApril 14, 2024 | investing.comPortage Down on Announcing AlternativesApril 12, 2024 | msn.comPortage Biotech Announces Plans to Expand its Evaluation of Strategic AlternativesApril 12, 2024 | globenewswire.comPortage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesMarch 26, 2024 | globenewswire.comPRTG: Extending the RunwayMarch 11, 2024 | finance.yahoo.comPortage Biotech Inc PRTGMarch 3, 2024 | morningstar.comPortage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business UpdateFebruary 28, 2024 | globenewswire.comH.C. Wainwright downgrades Portage Biotech on financing overhangJanuary 8, 2024 | realmoney.thestreet.comPortage Biotech just downgraded at H.C. Wainwright, here's whyJanuary 8, 2024 | realmoney.thestreet.comPRTG: Bridging I-O: Working in Harmony with CheckpointsJanuary 8, 2024 | finance.yahoo.comPortage Biotech Shares Fall 6% on Job Reductions, Paused Drug Development ProgramJanuary 4, 2024 | marketwatch.comPortage Biotech To Pause INKT Clinical Development; To Evaluate Potential Strategic OptionsJanuary 4, 2024 | markets.businessinsider.comPortage Biotech to halt iNKT drug program, cut workforceJanuary 4, 2024 | msn.comPortage Biotech Reports Business and Strategic UpdateJanuary 4, 2024 | finance.yahoo.comPortage Biotech GAAP EPS of -$0.29November 28, 2023 | msn.comPortage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business UpdateNovember 28, 2023 | finance.yahoo.comPortage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer's (SITC) 38th Annual MeetingNovember 6, 2023 | benzinga.comPortage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual MeetingNovember 6, 2023 | finance.yahoo.comPortage Biotech files to sell 9.63M shares for holdersOctober 31, 2023 | msn.comPortage Biotech Announces $6.0 Million Registered Direct OfferingSeptember 29, 2023 | finance.yahoo.comPortage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare ConferenceSeptember 20, 2023 | finance.yahoo.comAnalyst Expectations for Portage Biotech's FutureSeptember 7, 2023 | markets.businessinsider.comPortage Biotech in Keytruda Collaboration With MerckSeptember 5, 2023 | marketwatch.comPortage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with KEYTRUDA® (Pembrolizumab) in Solid TumorsSeptember 5, 2023 | finance.yahoo.comCantor Fitzgerald Reiterates Portage Biotech (PRTG) Overweight RecommendationSeptember 1, 2023 | msn.comPortage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business UpdateAugust 30, 2023 | finance.yahoo.comHC Wainwright & Co. Maintains Portage Biotech (PRTG) Buy RecommendationAugust 2, 2023 | msn.com Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now PRTG Media Mentions By Week PRTG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTG News Sentiment▼0.150.60▲Average Medical News Sentiment PRTG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTG Articles This Week▼100▲PRTG Articles Average Week Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Acurx Pharmaceuticals News TherapeuticsMD News AIM ImmunoTech News HCW Biologics News Marinus Pharmaceuticals News Kazia Therapeutics News Sol-Gel Technologies News Aspira Women's Health News CervoMed News Imunon News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTG) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Portage Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRTG Stock Alerts